Eli Lilly bets $2.4B on Dice Therapeutics

The latest stories trending on MedCity News.

Editor's Pick

Top Story Eli Lilly Bets $2.4B on Dice Therapeutics' Oral Drugs for Psoriasis and More Eli Lilly's acquisition of Dice Therapeutics comes eight months after the biotech reported positive data from a Phase 1 study in psoriasis. Dice develops oral small molecule drugs intended to offer alternatives to biologic drugs that are injected or infused. The Best Way to Gain Access to Capital, Innovation, and Partnerships Join MedCity News on October 26th at Pegasus Park in Dallas, TX for one day full of innovative content, the right connections, investors and so much more. Save $200, Register Now

Featured News

Feds Warn Healthcare Providers About 'Obscure' Ransomware Gang HC3 recently warned healthcare providers about a "relatively unknown" ransomware gang named TimisoaraHackerTeam. The group leverages legitimate software tools like Microsoft's BitLocker and Jetico's BestCrypt to deliver its malware. FDA Places Arcellx Cell Therapy Under a Clinical Hold After Patient Death Arcellx attributes the death to limitations of the treatments that patients receive while their cell therapies are being manufactured. The company is working to expand these so-called bridging therapy options for patients. What Are the Challenges in Gaining Trust in Healthcare? In order to gain trust from communities, healthcare leaders will need more training on effective communication, said Dr. Vin Gupta, a pulmonologist and chief medical officer of Amazon Pharmacy. He made these comments last week during a panel at the AHIP 2023 conference in Portland. Heal's Co-Founders Launch New Startup to Help Older Patients & Their Caregivers Renee Dua and Nick Desai —the husband-and-wife duo who founded physician house call company Heal in 2014 — have launched another healthcare startup. The company, called Together by Renee, said it is the first app to use generative AI to manage time-consuming healthcare tasks for older patients, those with chronic diseases and their stressed-out caregivers. CVS Health Exec: The Behavioral Health Industry Needs a 'Common App' for Insurance There are a lot of administrative hurdles behavioral health providers have to go through to join an insurer's network. That's why the industry needs something similar to the "Common App" for applying to be in-network with insurers, said Cara McNulty, president of behavioral health and mental wellbeing at CVS Health. The Common App allows students to apply to multiple colleges through one application. Eli Lilly Bets $2.4B on Dice Therapeutics' Oral Drugs for Psoriasis and More Eli Lilly's acquisition of Dice Therapeutics comes eight months after the biotech reported positive data from a Phase 1 study in psoriasis. Dice develops oral small molecule drugs intended to offer alternatives to biologic drugs that are injected or infused. The Crucial Role of Medical Affairs in Bridging the Educational Gap Among Healthcare Professionals in Biosimilars Biosimilars represent an important therapeutic option in modern healthcare, offering cost-effective alternatives to complex biological drugs. The educational gap among healthcare professionals poses a challenge to their widespread adoption. Medical Affairs teams in the pharmaceutical industry are at the forefront of bridging this gap

Resources

How AI Helps Health Systems Improve the Quality of Care for Patients with Chronic Conditions Presented by MedCity News Discover how to utilize AI to proactively target patients at risk of chronic conditions and improve health outcomes. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe